Category

Archives

ROR

Administration of an LXR agonist promotes atherosclerotic lesion remodelling in murine inflammatory arthritis

191 views | May 20 2023

The study shows that the LXR agonist T0901317 improves cholesterol efflux and atherosclerotic lesion regression in murine arthritis, potentially offering therapeutic benefits for patients with rheumatoid arthritis and atherosclerotic cardiovascular disease. [Read the Full Post]